Lineage Cell Therapeutics, Inc. (LCTX)
1.03
-0.01
(-0.96%)
USD |
NYAM |
Oct 29, 16:00
Lineage Cell Therapeutics Price : 1.03 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | 1.05 | 1.06 | 1.02 | 1.03 | 937733.0 |
| Oct 28, 2026 | 1.03 | 1.045 | 1.01 | 1.04 | 1.077M |
| Oct 27, 2026 | 0.9925 | 1.04 | 0.9751 | 1.03 | 1.196M |
| Oct 26, 2026 | 1.00 | 1.01 | 0.9616 | 0.9969 | 1.908M |
| Oct 23, 2026 | 0.9657 | 1.015 | 0.9436 | 1.00 | 1.151M |
| Oct 22, 2026 | 0.9483 | 1.01 | 0.9401 | 0.985 | 1.347M |
| Oct 21, 2026 | 0.9865 | 0.9903 | 0.9376 | 0.9515 | 1.221M |
| Oct 20, 2026 | 0.9508 | 1.01 | 0.9508 | 0.9726 | 1.631M |
| Oct 19, 2026 | 0.9809 | 0.9997 | 0.94 | 0.9528 | 955553.0 |
| Oct 16, 2026 | 0.98 | 1.00 | 0.96 | 0.9783 | 1.309M |
| Oct 15, 2026 | 0.9212 | 0.9994 | 0.918 | 0.9903 | 1.425M |
| Oct 14, 2026 | 0.9142 | 0.94 | 0.8902 | 0.9175 | 2.201M |
| Oct 13, 2026 | 0.95 | 0.97 | 0.895 | 0.9083 | 1.785M |
| Oct 12, 2026 | 0.9979 | 0.9979 | 0.9383 | 0.9541 | 1.687M |
| Oct 09, 2026 | 1.02 | 1.025 | 0.98 | 0.994 | 1.159M |
| Oct 08, 2026 | 0.9494 | 1.045 | 0.93 | 1.03 | 2.010M |
| Oct 07, 2026 | 0.9424 | 0.965 | 0.9212 | 0.9476 | 1.477M |
| Oct 06, 2026 | 0.9411 | 0.965 | 0.925 | 0.9379 | 967621.0 |
| Oct 05, 2026 | 0.93 | 0.9604 | 0.9118 | 0.9274 | 1.387M |
| Oct 02, 2026 | 0.921 | 0.96 | 0.8913 | 0.9303 | 1.249M |
| Oct 01, 2026 | 0.9581 | 0.97 | 0.8823 | 0.9042 | 1.652M |
| Sep 30, 2026 | 0.9503 | 0.9882 | 0.9421 | 0.9557 | 1.268M |
| Sep 29, 2026 | 0.98 | 0.99 | 0.9202 | 0.9475 | 2.592M |
| Sep 28, 2026 | 1.02 | 1.04 | 0.96 | 0.971 | 1.574M |
| Sep 25, 2026 | 0.95 | 1.04 | 0.9419 | 1.03 | 2.482M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.07 |
| Amgen, Inc. | 473.20 |
| Anika Therapeutics, Inc. | 21.79 |
| BioCryst Pharmaceuticals, Inc. | 8.57 |
| Imunon, Inc. | 0.8568 |
Price Related Metrics
| PS Ratio | 19.58 |
| PEG Ratio | -6.003 |
| Price to Book Value | 4.276 |
| Earnings Yield | -17.89% |
| Market Cap | 260.49M |
| PEGY Ratio | -6.003 |